The University of Chicago Header Logo

Connection

Samuel G. Armato to Mesothelioma

Back to Details
This is a "connection" page, showing publications Samuel G. Armato has written about Mesothelioma.
Samuel G. Armato
Connection Strength
9.119
Mesothelioma
  1. Considerations for Imaging of Malignant Pleural Mesothelioma: A Consensus Statement from the International Mesothelioma Interest Group. J Thorac Oncol. 2023 03; 18(3):278-298.
    View in: PubMed
    Score: 0.704
  2. Imaging in pleural mesothelioma: A review of the 15th International Conference of the International Mesothelioma Interest Group. Lung Cancer. 2022 02; 164:76-83.
    View in: PubMed
    Score: 0.657
  3. Correlation of patient survival with clinical tumor measurements in malignant pleural mesothelioma. Eur Radiol. 2019 Jun; 29(6):2981-2988.
    View in: PubMed
    Score: 0.536
  4. Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group. Lung Cancer. 2019 04; 130:108-114.
    View in: PubMed
    Score: 0.532
  5. Revised Modified Response Evaluation Criteria in Solid Tumors for Assessment of Response in Malignant Pleural Mesothelioma (Version 1.1). J Thorac Oncol. 2018 07; 13(7):1012-1021.
    View in: PubMed
    Score: 0.511
  6. Imaging in pleural mesothelioma: A review of the 13th International Conference of the International Mesothelioma Interest Group. Lung Cancer. 2016 11; 101:48-58.
    View in: PubMed
    Score: 0.455
  7. Imaging in pleural mesothelioma: A review of the 12th International Conference of the International Mesothelioma Interest Group. Lung Cancer. 2015 Nov; 90(2):148-54.
    View in: PubMed
    Score: 0.422
  8. Radiologic-pathologic correlation of mesothelioma tumor volume. Lung Cancer. 2015 Mar; 87(3):278-82.
    View in: PubMed
    Score: 0.407
  9. Observer variability in mesothelioma tumor thickness measurements: defining minimally measurable lesions. J Thorac Oncol. 2014 Aug; 9(8):1187-94.
    View in: PubMed
    Score: 0.394
  10. Imaging in pleural mesothelioma: a review of the 11th International Conference of the International Mesothelioma Interest Group. Lung Cancer. 2013 Nov; 82(2):190-6.
    View in: PubMed
    Score: 0.368
  11. Variability of tumor area measurements for response assessment in malignant pleural mesothelioma. Med Phys. 2013 Aug; 40(8):081916.
    View in: PubMed
    Score: 0.367
  12. Disease volumes as a marker for patient response in malignant pleural mesothelioma. Ann Oncol. 2013 Apr; 24(4):999-1005.
    View in: PubMed
    Score: 0.349
  13. Characterization of mesothelioma and tissues present in contrast-enhanced thoracic CT scans. Med Phys. 2011 Feb; 38(2):942-7.
    View in: PubMed
    Score: 0.309
  14. Current state and future directions of pleural mesothelioma imaging. Lung Cancer. 2008 Mar; 59(3):411-20.
    View in: PubMed
    Score: 0.248
  15. Variability in mesothelioma tumor response classification. AJR Am J Roentgenol. 2006 Apr; 186(4):1000-6.
    View in: PubMed
    Score: 0.221
  16. The radiologic measurement of mesothelioma. Hematol Oncol Clin North Am. 2005 Dec; 19(6):1053-66, vi.
    View in: PubMed
    Score: 0.216
  17. Evaluation of semiautomated measurements of mesothelioma tumor thickness on CT scans. Acad Radiol. 2005 Oct; 12(10):1301-9.
    View in: PubMed
    Score: 0.214
  18. Computerized analysis of mesothelioma on CT scans. Lung Cancer. 2005 Jul; 49 Suppl 1:S41-4.
    View in: PubMed
    Score: 0.206
  19. Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques. Med Phys. 2004 May; 31(5):1105-15.
    View in: PubMed
    Score: 0.194
  20. Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma. JAMA Netw Open. 2023 08 01; 6(8):e2327351.
    View in: PubMed
    Score: 0.184
  21. The role of imaging in diagnosis and management of malignant peritoneal mesothelioma: a systematic review. Abdom Radiol (NY). 2022 05; 47(5):1725-1740.
    View in: PubMed
    Score: 0.167
  22. Optimization of response classification criteria for patients with malignant pleural mesothelioma, a validation study. Lung Cancer. 2019 12; 138:139-140.
    View in: PubMed
    Score: 0.142
  23. EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach. J Thorac Oncol. 2020 01; 15(1):29-49.
    View in: PubMed
    Score: 0.141
  24. Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting. J Thorac Oncol. 2019 10; 14(10):1718-1731.
    View in: PubMed
    Score: 0.140
  25. Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2018 05 01; 36(13):1343-1373.
    View in: PubMed
    Score: 0.125
  26. North American Multicenter Volumetric CT Study for Clinical Staging of Malignant Pleural Mesothelioma: Feasibility and Logistics of Setting Up a Quantitative Imaging Study. J Thorac Oncol. 2016 08; 11(8):1335-1344.
    View in: PubMed
    Score: 0.111
  27. Lung volume measurements as a surrogate marker for patient response in malignant pleural mesothelioma. J Thorac Oncol. 2013 Apr; 8(4):478-86.
    View in: PubMed
    Score: 0.090
  28. Optimization of response classification criteria for patients with malignant pleural mesothelioma. J Thorac Oncol. 2012 Nov; 7(11):1728-34.
    View in: PubMed
    Score: 0.087
  29. Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma. J Clin Oncol. 2012 Jul 10; 30(20):2509-15.
    View in: PubMed
    Score: 0.085
  30. Three-dimensional stereoscopic volume rendering of malignant pleural mesothelioma. Int Surg. 2012 Jan-Mar; 97(1):65-70.
    View in: PubMed
    Score: 0.082
  31. Computerized segmentation and measurement of malignant pleural mesothelioma. Med Phys. 2011 Jan; 38(1):238-44.
    View in: PubMed
    Score: 0.077
  32. Quantitative measurement of lung reexpansion in malignant pleural mesothelioma patients undergoing pleurectomy/decortication. Acad Radiol. 2011 Mar; 18(3):294-8.
    View in: PubMed
    Score: 0.076
  33. Imaging in pleural mesothelioma: a review of imaging research presented at the 9th International Meeting of the International Mesothelioma Interest Group. Lung Cancer. 2010 Oct; 70(1):1-6.
    View in: PubMed
    Score: 0.074
  34. The influence of initial outlines on manual segmentation. Med Phys. 2010 May; 37(5):2153-8.
    View in: PubMed
    Score: 0.073
  35. Modeling of mesothelioma growth demonstrates weaknesses of current response criteria. Lung Cancer. 2006 May; 52(2):141-8.
    View in: PubMed
    Score: 0.055
  36. Automated matching of temporally sequential CT sections. Med Phys. 2004 Dec; 31(12):3417-24.
    View in: PubMed
    Score: 0.050
  37. Automated lung segmentation for thoracic CT impact on computer-aided diagnosis. Acad Radiol. 2004 Sep; 11(9):1011-21.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.